Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Visx

This article was originally published in The Gray Sheet

Executive Summary

Is "hopeful" that a premarket approval application for its Twenty/Twenty excimer laser for phototherapeutic keratectomy will be reviewed at the next meeting of FDA's Ophthalmic Devices Panel, scheduled for March 21-22. Use of the excimer laser for PTK "was one subject discussed during a closed door session" of the panel last October, the company says in its third quarter 1993 report
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT001818

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel